Regulus Therapeutics Inc. buy SVB Leerink LLC
Start price
18.03.24
/
50%
€2.10
Target price
18.03.25
€5.51
Performance (%)
-40.48%
End price
19.03.25
€1.25
Summary
This prediction ended on 19.03.25 with a price of €1.25. The BUY prediction by SVB_Leerink_LLC for Regulus Therapeutics Inc. performed very badly with a performance of -40.48%. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regulus Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -1,34 % | -5,62 % | 3,38 % |
| iShares Nasdaq 100 | -1,07 % | 2,60 % | 19,13 % |
| iShares Nikkei 225® | -1,99 % | -6,51 % | 27,85 % |
| iShares S&P 500 | -1,32 % | 0,91 % | 14,19 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $6.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
In the thread Trading Regulus Therapeutics Inc.
Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten